Clare Fisher joined BeiGene in July 2021 as SVP Business Development and Mergers & Acquisitions, offering over 20 years of experience in healthcare, including leadership roles in corporate and business development, M&A, and strategy. Prior to joining Beigene, Ms. Fisher served as Kaleido Bioscience’s Chief Business Officer, a company dedicated to targeting the microbiome to treat a variety of diseases. Ms. Fisher previously also held senior global roles at Shire plc, Cubist Pharmaceuticals, Blueprint Medicines, and Genzyme Corporation leading collaborations, licensing, M&A, investments and divestments across many technologies and therapeutic areas. Ms. Fisher holds a B.S. in Biochemistry from the University of Bath, as well as an M.B.A. from Henley Management College in the U.K.
Sign up to view 2 direct reports
Get started
This person is not in any teams